drugset / Trial / NCT00887601
BOLD Functional Magnetic Resonance Imaging (fMRI) and Cerebral Blood Flow Measurements as Biomarkers for Cognition Enhancing Drugs (3134-006)
RandomizedCrossoverDouble-blindDiagnostic
Summary
This study will evaluate functional magnetic resonance imaging (fMRI) and methods for measuring drug induced changes in cerebral blood flow as biomarkers for attention-improving drugs.
Timeline
- Start
- 2007-08
- Primary completion
- 2008-05
- Completion
- 2008-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Donepezil | Small molecule | 5 mg | — |
| Subject | MK3134 | Unknown | 1 mg | — |
| Subject | MK3134 | Unknown | 5 mg | — |
| Subject | MK3134 | Unknown | 25 mg | — |